| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -120 @ USD 118.75 | USD -14,250 | The ETF sold 120 shares of DVA on 2025-10-30. The shares were previously bought for an average price of USD 147.875. The DaVita HealthCare Partners Inc shares were sold for -19.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,495 The average price that the ETF previously sold DVA share for is USD 143.06 which is higher than the selling price of USD 118.75 on 2025-10-30. |
| HSIC - Henry Schein Inc | SELL | -348 @ USD 62.9 | USD -21,889 | The ETF sold 348 shares of HSIC on 2025-10-30. The shares were previously bought for an average price of USD 71.0384. The Henry Schein Inc shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,832 The average price that the ETF previously sold HSIC share for is USD 69.8726 which is higher than the selling price of USD 62.9 on 2025-10-30. |
| MOH - MOH | SELL | -180 @ USD 151.1 | USD -27,198 | The ETF sold 180 shares of MOH on 2025-10-30. The shares were previously bought for an average price of USD 277.252. The MOH shares were sold for -45.5% lower than average price of previous purchases. This resulted in an overall loss of USD 22,707 The average price that the ETF previously sold MOH share for is USD 298.277 which is higher than the selling price of USD 151.1 on 2025-10-30. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -180 @ USD 151.1 | USD -27,198 | The ETF sold 180 shares of MOH on 2025-10-30. The shares were previously bought for an average price of USD 277.252. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -45.5% lower than average price of previous purchases. This resulted in an overall loss of USD 22,707 The average price that the ETF previously sold MOH share for is USD 298.277 which is higher than the selling price of USD 151.1 on 2025-10-30. |
| CRL - Creightons Plc | SELL | -162 @ USD 179.11 | USD -29,016 | The ETF sold 162 shares of CRL on 2025-10-30. The shares were previously bought for an average price of USD 167.04. The Creightons Plc shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 1,955 The average price that the ETF previously sold CRL share for is USD 173.547 so the ETF has sold 162 shares on 2025-10-30 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -222 @ USD 138.43 | USD -30,731 | The ETF sold 222 shares of ALGN on 2025-10-30. The shares were previously bought for an average price of USD 176.875. The Align Technology Inc shares were sold for -21.7% lower than average price of previous purchases. This resulted in an overall loss of USD 8,535 The average price that the ETF previously sold ALGN share for is USD 202.706 which is higher than the selling price of USD 138.43 on 2025-10-30. |
| TECH - Bio-Techne Corp | SELL | -522 @ USD 60.96 | USD -31,821 | The ETF sold 522 shares of TECH on 2025-10-30. The shares were previously bought for an average price of USD 62.6113. The Bio-Techne Corp shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 862 The average price that the ETF previously sold TECH share for is USD 65.2307 which is higher than the selling price of USD 60.96 on 2025-10-30. |
| MRNA - Moderna Inc | SELL | -1,152 @ USD 28.14 | USD -32,417 | The ETF sold 1152 shares of MRNA on 2025-10-30. The shares were previously bought for an average price of USD 32.5101. The Moderna Inc shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,034 The average price that the ETF previously sold MRNA share for is USD 37.6527 which is higher than the selling price of USD 28.14 on 2025-10-30. |
| BAX - Baxter International Inc | SELL | -1,722 @ USD 19.16 | USD -32,994 | The ETF sold 1722 shares of BAX on 2025-10-30. The shares were previously bought for an average price of USD 30.4215. The Baxter International Inc shares were sold for -37.0% lower than average price of previous purchases. This resulted in an overall loss of USD 19,392 The average price that the ETF previously sold BAX share for is USD 31.9585 which is higher than the selling price of USD 19.16 on 2025-10-30. |
| SOLV - Solventum Corp. | SELL | -486 @ USD 69.28 | USD -33,670 | The ETF sold 486 shares of SOLV on 2025-10-30. The shares were previously bought for an average price of USD 73.6154. The Solventum Corp. shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,107 The average price that the ETF previously sold SOLV share for is USD 72.1139 which is higher than the selling price of USD 69.28 on 2025-10-30. |
| RVTY - Revvity Inc. | SELL | -390 @ USD 91.02 | USD -35,498 | The ETF sold 390 shares of RVTY on 2025-10-30. The shares were previously bought for an average price of USD 106.66. The Revvity Inc. shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,100 The average price that the ETF previously sold RVTY share for is USD 107.319 which is higher than the selling price of USD 91.02 on 2025-10-30. |
| VTRS - Viatris Inc | SELL | -3,870 @ USD 10.36 | USD -40,093 | The ETF sold 3870 shares of VTRS on 2025-10-30. The shares were previously bought for an average price of USD 10.2289. The Viatris Inc shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 507 The average price that the ETF previously sold VTRS share for is USD 10.9871 which is higher than the selling price of USD 10.36 on 2025-10-30. |
| UHS - Universal Health Services Inc | SELL | -186 @ USD 218.69 | USD -40,676 | The ETF sold 186 shares of UHS on 2025-10-30. The shares were previously bought for an average price of USD 190.695. The Universal Health Services Inc shares were sold for 14.7% higher than average price of previous purchases. This sale made a profit of USD 5,207 The average price that the ETF previously sold UHS share for is USD 192.319 so the ETF has sold 186 shares on 2025-10-30 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -666 @ USD 70.11 | USD -46,693 | The ETF sold 666 shares of COO on 2025-10-30. The shares were previously bought for an average price of USD 83.4761. The The Cooper Companies, Inc. Common Stock shares were sold for -16.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,902 The average price that the ETF previously sold COO share for is USD 90.0048 which is higher than the selling price of USD 70.11 on 2025-10-30. |
| INCY - Incyte Corporation | SELL | -552 @ USD 92.59 | USD -51,110 | The ETF sold 552 shares of INCY on 2025-10-30. The shares were previously bought for an average price of USD 74.359. The Incyte Corporation shares were sold for 24.5% higher than average price of previous purchases. This sale made a profit of USD 10,064 The average price that the ETF previously sold INCY share for is USD 72.8781 so the ETF has sold 552 shares on 2025-10-30 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -1,566 @ USD 35.02 | USD -54,841 | The ETF sold 1566 shares of CNC on 2025-10-30. The shares were previously bought for an average price of USD 53.7617. The Concurrent Technologies Plc shares were sold for -34.9% lower than average price of previous purchases. This resulted in an overall loss of USD 29,350 The average price that the ETF previously sold CNC share for is USD 51.7156 which is higher than the selling price of USD 35.02 on 2025-10-30. |
| HOLX - Hologic Inc | SELL | -744 @ USD 73.93 | USD -55,004 | The ETF sold 744 shares of HOLX on 2025-10-30. The shares were previously bought for an average price of USD 66.9773. The Hologic Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 5,173 The average price that the ETF previously sold HOLX share for is USD 70.4716 so the ETF has sold 744 shares on 2025-10-30 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -234 @ USD 278.54 | USD -65,178 | The ETF sold 234 shares of WST on 2025-10-30. The shares were previously bought for an average price of USD 257.436. The West Pharmaceutical Services Inc shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 4,938 The average price that the ETF previously sold WST share for is USD 278.683 which is higher than the selling price of USD 278.54 on 2025-10-30. |
| DGX - Quest Diagnostics Incorporated | SELL | -372 @ USD 175.75 | USD -65,379 | The ETF sold 372 shares of DGX on 2025-10-30. The shares were previously bought for an average price of USD 171.31. The Quest Diagnostics Incorporated shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 1,652 The average price that the ETF previously sold DGX share for is USD 166.247 so the ETF has sold 372 shares on 2025-10-30 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -666 @ USD 99.56 | USD -66,307 | The ETF sold 666 shares of ZBH on 2025-10-30. The shares were previously bought for an average price of USD 103.868. The Zimmer Biomet Holdings Inc shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,869 The average price that the ETF previously sold ZBH share for is USD 104.35 which is higher than the selling price of USD 99.56 on 2025-10-30. |
| WAT - Waters Corporation | SELL | -198 @ USD 342.9 | USD -67,894 | The ETF sold 198 shares of WAT on 2025-10-30. The shares were previously bought for an average price of USD 355.33. The Waters Corporation shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,461 The average price that the ETF previously sold WAT share for is USD 362.22 which is higher than the selling price of USD 342.9 on 2025-10-30. |
| WAT - MULETFWATIMETFP | SELL | -198 @ USD 342.9 | USD -67,894 | The ETF sold 198 shares of WAT on 2025-10-30. The shares were previously bought for an average price of USD 355.33. The MULETFWATIMETFP shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,461 The average price that the ETF previously sold WAT share for is USD 362.22 which is higher than the selling price of USD 342.9 on 2025-10-30. |
| LH - Laboratory Corporation of America Holdings | SELL | -276 @ USD 252.33 | USD -69,643 | The ETF sold 276 shares of LH on 2025-10-30. The shares were previously bought for an average price of USD 253.171. The Laboratory Corporation of America Holdings shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 232 The average price that the ETF previously sold LH share for is USD 243.94 so the ETF has sold 276 shares on 2025-10-30 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -228 @ USD 311.95 | USD -71,125 | The ETF sold 228 shares of PODD on 2025-10-30. The shares were previously bought for an average price of USD 285.772. The Insulet Corporation shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 5,969 The average price that the ETF previously sold PODD share for is USD 276.142 so the ETF has sold 228 shares on 2025-10-30 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -486 @ USD 149.61 | USD -72,710 | The ETF sold 486 shares of BIIB on 2025-10-30. The shares were previously bought for an average price of USD 142.616. The Biogen Inc shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 3,399 The average price that the ETF previously sold BIIB share for is USD 151.504 which is higher than the selling price of USD 149.61 on 2025-10-30. |
| STE - STERIS plc | SELL | -330 @ USD 236.19 | USD -77,943 | The ETF sold 330 shares of STE on 2025-10-30. The shares were previously bought for an average price of USD 227.793. The STERIS plc shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 2,771 The average price that the ETF previously sold STE share for is USD 224.155 so the ETF has sold 330 shares on 2025-10-30 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -1,314 @ USD 68.2 | USD -89,615 | The ETF sold 1314 shares of DXCM on 2025-10-30. The shares were previously bought for an average price of USD 76.3452. The DexCom Inc shares were sold for -10.7% lower than average price of previous purchases. This resulted in an overall loss of USD 10,703 The average price that the ETF previously sold DXCM share for is USD 76.9282 which is higher than the selling price of USD 68.2 on 2025-10-30. |
| MTD - Mettler-Toledo International Inc | SELL | -66 @ USD 1377.01 | USD -90,883 | The ETF sold 66 shares of MTD on 2025-10-30. The shares were previously bought for an average price of USD 1253.12. The Mettler-Toledo International Inc shares were sold for 9.9% higher than average price of previous purchases. This sale made a profit of USD 8,177 The average price that the ETF previously sold MTD share for is USD 1234.57 so the ETF has sold 66 shares on 2025-10-30 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -66 @ USD 1377.01 | USD -90,883 | The ETF sold 66 shares of MTD on 2025-10-30. The shares were previously bought for an average price of USD 1253.12. The AMUNDI EUR GOV 710 shares were sold for 9.9% higher than average price of previous purchases. This sale made a profit of USD 8,177 The average price that the ETF previously sold MTD share for is USD 1234.57 so the ETF has sold 66 shares on 2025-10-30 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,530 @ USD 75 | USD -114,750 | The ETF sold 1530 shares of GEHC on 2025-10-30. The shares were previously bought for an average price of USD 80.6137. The GE HealthCare Technologies Inc. shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,589 The average price that the ETF previously sold GEHC share for is USD 79.433 which is higher than the selling price of USD 75 on 2025-10-30. |
| HUM - Hummingbird Resources PLC | SELL | -402 @ USD 285.61 | USD -114,815 | The ETF sold 402 shares of HUM on 2025-10-30. The shares were previously bought for an average price of USD 265.871. The Hummingbird Resources PLC shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 7,935 The average price that the ETF previously sold HUM share for is USD 270.303 so the ETF has sold 402 shares on 2025-10-30 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -402 @ USD 285.61 | USD -114,815 | The ETF sold 402 shares of HUM on 2025-10-30. The shares were previously bought for an average price of USD 265.871. The Humana Inc shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 7,935 The average price that the ETF previously sold HUM share for is USD 270.303 so the ETF has sold 402 shares on 2025-10-30 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -564 @ USD 216.47 | USD -122,089 | The ETF sold 564 shares of IQV on 2025-10-30. The shares were previously bought for an average price of USD 189.088. The IQVIA Holdings Inc shares were sold for 14.5% higher than average price of previous purchases. This sale made a profit of USD 15,443 The average price that the ETF previously sold IQV share for is USD 187.24 so the ETF has sold 564 shares on 2025-10-30 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -492 @ USD 252.26 | USD -124,112 | The ETF sold 492 shares of RMD on 2025-10-30. The shares were previously bought for an average price of USD 245.8. The ResMed Inc shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of USD 3,178 The average price that the ETF previously sold RMD share for is USD 246.585 so the ETF has sold 492 shares on 2025-10-30 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -954 @ USD 143.36 | USD -136,765 | The ETF sold 954 shares of A on 2025-10-30. The shares were previously bought for an average price of USD 129.656. The Agilent Technologies Inc shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 13,074 The average price that the ETF previously sold A share for is USD 129.175 so the ETF has sold 954 shares on 2025-10-30 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -792 @ USD 189.84 | USD -150,353 | The ETF sold 792 shares of CAH on 2025-10-30. The shares were previously bought for an average price of USD 137.666. The Cardinal Health Inc shares were sold for 37.9% higher than average price of previous purchases. This sale made a profit of USD 41,322 The average price that the ETF previously sold CAH share for is USD 135.692 so the ETF has sold 792 shares on 2025-10-30 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,974 @ USD 83.48 | USD -164,790 | The ETF sold 1974 shares of EW on 2025-10-30. The shares were previously bought for an average price of USD 72.5948. The Edwards Lifesciences Corp shares were sold for 15.0% higher than average price of previous purchases. This sale made a profit of USD 21,487 The average price that the ETF previously sold EW share for is USD 71.6258 so the ETF has sold 1974 shares on 2025-10-30 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -264 @ USD 628.54 | USD -165,935 | The ETF sold 264 shares of IDXX on 2025-10-30. The shares were previously bought for an average price of USD 495.08. The IDEXX Laboratories Inc shares were sold for 27.0% higher than average price of previous purchases. This sale made a profit of USD 35,233 The average price that the ETF previously sold IDXX share for is USD 469.64 so the ETF has sold 264 shares on 2025-10-30 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -960 @ USD 179.38 | USD -172,205 | The ETF sold 960 shares of BDX on 2025-10-30. The shares were previously bought for an average price of USD 212.777. The Becton Dickinson and Company shares were sold for -15.7% lower than average price of previous purchases. This resulted in an overall loss of USD 32,061 The average price that the ETF previously sold BDX share for is USD 208.676 which is higher than the selling price of USD 179.38 on 2025-10-30. |
| ZTS - Zoetis Inc | SELL | -1,488 @ USD 144.1 | USD -214,421 | The ETF sold 1488 shares of ZTS on 2025-10-30. The shares were previously bought for an average price of USD 161.002. The Zoetis Inc shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of USD 25,150 The average price that the ETF previously sold ZTS share for is USD 168.621 which is higher than the selling price of USD 144.1 on 2025-10-30. |
| CI - Cigna Corp | SELL | -894 @ USD 247.1 | USD -220,907 | The ETF sold 894 shares of CI on 2025-10-30. The shares were previously bought for an average price of USD 309.98. The Cigna Corp shares were sold for -20.3% lower than average price of previous purchases. This resulted in an overall loss of USD 56,215 The average price that the ETF previously sold CI share for is USD 318.54 which is higher than the selling price of USD 247.1 on 2025-10-30. |
| COR - Cencora Inc. | SELL | -648 @ USD 341.21 | USD -221,104 | The ETF sold 648 shares of COR on 2025-10-30. The shares were previously bought for an average price of USD 289.268. The Cencora Inc. shares were sold for 18.0% higher than average price of previous purchases. This sale made a profit of USD 33,658 The average price that the ETF previously sold COR share for is USD 264.571 so the ETF has sold 648 shares on 2025-10-30 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -342 @ USD 654.04 | USD -223,682 | The ETF sold 342 shares of REGN on 2025-10-30. The shares were previously bought for an average price of USD 655.899. The Regeneron Pharmaceuticals Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 636 The average price that the ETF previously sold REGN share for is USD 683.839 which is higher than the selling price of USD 654.04 on 2025-10-30. |
| ELV - Elevance Health Inc | SELL | -750 @ USD 321.95 | USD -241,463 | The ETF sold 750 shares of ELV on 2025-10-30. The shares were previously bought for an average price of USD 387.456. The Elevance Health Inc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 49,130 The average price that the ETF previously sold ELV share for is USD 394.67 which is higher than the selling price of USD 321.95 on 2025-10-30. |
| ELV - Elevance Health Inc | SELL | -750 @ USD 321.95 | USD -241,463 | The ETF sold 750 shares of ELV on 2025-10-30. The shares were previously bought for an average price of USD 387.456. The Elevance Health Inc shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 49,130 The average price that the ETF previously sold ELV share for is USD 394.67 which is higher than the selling price of USD 321.95 on 2025-10-30. |
| HCA - HCA Holdings Inc | SELL | -546 @ USD 466.8 | USD -254,873 | The ETF sold 546 shares of HCA on 2025-10-30. The shares were previously bought for an average price of USD 362.584. The HCA Holdings Inc shares were sold for 28.7% higher than average price of previous purchases. This sale made a profit of USD 56,902 The average price that the ETF previously sold HCA share for is USD 363.181 so the ETF has sold 546 shares on 2025-10-30 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -6,828 @ USD 45.62 | USD -311,493 | The ETF sold 6828 shares of BMY on 2025-10-30. The shares were previously bought for an average price of USD 52.9312. The Bloomsbury Publishing Plc shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 49,921 The average price that the ETF previously sold BMY share for is USD 53.5752 which is higher than the selling price of USD 45.62 on 2025-10-30. |
| MCK - McKesson Corporation | SELL | -414 @ USD 825.53 | USD -341,769 | The ETF sold 414 shares of MCK on 2025-10-30. The shares were previously bought for an average price of USD 667.626. The McKesson Corporation shares were sold for 23.7% higher than average price of previous purchases. This sale made a profit of USD 65,372 The average price that the ETF previously sold MCK share for is USD 651.288 so the ETF has sold 414 shares on 2025-10-30 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -858 @ USD 419.89 | USD -360,266 | The ETF sold 858 shares of VRTX on 2025-10-30. The shares were previously bought for an average price of USD 451.2. The Vertex Pharmaceuticals Inc shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 26,864 The average price that the ETF previously sold VRTX share for is USD 470.368 which is higher than the selling price of USD 419.89 on 2025-10-30. |
| MDT - Medtronic PLC | SELL | -4,302 @ USD 90.97 | USD -391,353 | The ETF sold 4302 shares of MDT on 2025-10-30. The shares were previously bought for an average price of USD 90.0119. The Medtronic PLC shares were sold for 1.1% higher than average price of previous purchases. This sale made a profit of USD 4,122 The average price that the ETF previously sold MDT share for is USD 87.1806 so the ETF has sold 4302 shares on 2025-10-30 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -1,152 @ USD 368.98 | USD -425,065 | The ETF sold 1152 shares of SYK on 2025-10-30. The shares were previously bought for an average price of USD 377.913. The Stryker Corporation shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,291 The average price that the ETF previously sold SYK share for is USD 380.746 which is higher than the selling price of USD 368.98 on 2025-10-30. |
| CVS - CVS Health Corp | SELL | -5,668 @ USD 76.69 | USD -434,679 | The ETF sold 5668 shares of CVS on 2025-10-30. The shares were previously bought for an average price of USD 67.1805. The CVS Health Corp shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 53,900 The average price that the ETF previously sold CVS share for is USD 60.5824 so the ETF has sold 5668 shares on 2025-10-30 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -2,130 @ USD 215.05 | USD -458,057 | The ETF sold 2130 shares of DHR on 2025-10-30. The shares were previously bought for an average price of USD 213.336. The Danaher Corporation shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 3,651 The average price that the ETF previously sold DHR share for is USD 222.486 which is higher than the selling price of USD 215.05 on 2025-10-30. |
| DHR - Danaher Corporation | SELL | -2,130 @ USD 215.05 | USD -458,057 | The ETF sold 2130 shares of DHR on 2025-10-30. The shares were previously bought for an average price of USD 213.336. The Danaher Corporation shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 3,651 The average price that the ETF previously sold DHR share for is USD 222.486 which is higher than the selling price of USD 215.05 on 2025-10-30. |
| PFE - Pfizer Inc | SELL | -19,110 @ USD 24.29 | USD -464,182 | The ETF sold 19110 shares of PFE on 2025-10-30. The shares were previously bought for an average price of USD 25.4466. The Pfizer Inc shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 22,103 The average price that the ETF previously sold PFE share for is USD 25.395 which is higher than the selling price of USD 24.29 on 2025-10-30. |
| GILD - Guild Esports Plc | SELL | -4,164 @ USD 118.44 | USD -493,184 | The ETF sold 4164 shares of GILD on 2025-10-30. The shares were previously bought for an average price of USD 106.548. The Guild Esports Plc shares were sold for 11.2% higher than average price of previous purchases. This sale made a profit of USD 49,518 The average price that the ETF previously sold GILD share for is USD 99.7816 so the ETF has sold 4164 shares on 2025-10-30 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -4,974 @ USD 100.57 | USD -500,235 | The ETF sold 4974 shares of BSX on 2025-10-30. The shares were previously bought for an average price of USD 99.2558. The Boston Scientific Corporation shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 6,537 The average price that the ETF previously sold BSX share for is USD 94.3916 so the ETF has sold 4974 shares on 2025-10-30 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,974 @ USD 100.57 | USD -500,235 | The ETF sold 4974 shares of BSX on 2025-10-30. The shares were previously bought for an average price of USD 99.2558. The MULSTRXSSXIMETFP shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 6,537 The average price that the ETF previously sold BSX share for is USD 94.3916 so the ETF has sold 4974 shares on 2025-10-30 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,800 @ USD 292 | USD -525,600 | The ETF sold 1800 shares of AMGN on 2025-10-30. The shares were previously bought for an average price of USD 298.087. The Amgen Inc shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 10,957 The average price that the ETF previously sold AMGN share for is USD 293.87 which is higher than the selling price of USD 292 on 2025-10-30. |
| ISRG - Intuitive Surgical Inc | SELL | -1,200 @ USD 530.02 | USD -636,024 | The ETF sold 1200 shares of ISRG on 2025-10-30. The shares were previously bought for an average price of USD 515.907. The Intuitive Surgical Inc shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of USD 16,936 The average price that the ETF previously sold ISRG share for is USD 528.485 so the ETF has sold 1200 shares on 2025-10-30 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -1,266 @ USD 556.22 | USD -704,175 | The ETF sold 1266 shares of TMO on 2025-10-30. The shares were previously bought for an average price of USD 510.754. The Time Out Group plc shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 57,560 The average price that the ETF previously sold TMO share for is USD 493.071 so the ETF has sold 1266 shares on 2025-10-30 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -8,388 @ USD 86.28 | USD -723,717 | The ETF sold 8388 shares of MRK on 2025-10-30. The shares were previously bought for an average price of USD 89.2257. The Marks Electrical Group PLC shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 24,709 The average price that the ETF previously sold MRK share for is USD 93.1734 which is higher than the selling price of USD 86.28 on 2025-10-30. |
| MRK - Merck & Company Inc | SELL | -8,388 @ USD 86.28 | USD -723,717 | The ETF sold 8388 shares of MRK on 2025-10-30. The shares were previously bought for an average price of USD 89.2257. The Merck & Company Inc shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of USD 24,709 The average price that the ETF previously sold MRK share for is USD 93.1734 which is higher than the selling price of USD 86.28 on 2025-10-30. |
| ABT - Abbott Laboratories | SELL | -5,844 @ USD 124.67 | USD -728,571 | The ETF sold 5844 shares of ABT on 2025-10-30. The shares were previously bought for an average price of USD 128.714. The Abbott Laboratories shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 23,633 The average price that the ETF previously sold ABT share for is USD 123.08 so the ETF has sold 5844 shares on 2025-10-30 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -3,030 @ USD 344.75 | USD -1,044,593 | The ETF sold 3030 shares of UNH on 2025-10-30. The shares were previously bought for an average price of USD 457.323. The UnitedHealth Group Incorporated shares were sold for -24.6% lower than average price of previous purchases. This resulted in an overall loss of USD 341,096 The average price that the ETF previously sold UNH share for is USD 486.418 which is higher than the selling price of USD 344.75 on 2025-10-30. |
| ABBV - AbbVie Inc | SELL | -5,886 @ USD 228.2 | USD -1,343,185 | The ETF sold 5886 shares of ABBV on 2025-10-30. The shares were previously bought for an average price of USD 200.429. The AbbVie Inc shares were sold for 13.9% higher than average price of previous purchases. This sale made a profit of USD 163,460 The average price that the ETF previously sold ABBV share for is USD 188.686 so the ETF has sold 5886 shares on 2025-10-30 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -8,022 @ USD 189.05 | USD -1,516,559 | The ETF sold 8022 shares of JNJ on 2025-10-30. The shares were previously bought for an average price of USD 164.252. The Johnson & Johnson shares were sold for 15.1% higher than average price of previous purchases. This sale made a profit of USD 198,930 The average price that the ETF previously sold JNJ share for is USD 156.3 so the ETF has sold 8022 shares on 2025-10-30 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -2,634 @ USD 844.5 | USD -2,224,413 | The ETF sold 2634 shares of LLY on 2025-10-30. The shares were previously bought for an average price of USD 815.09. The Eli Lilly and Company shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of USD 77,466 The average price that the ETF previously sold LLY share for is USD 794.737 so the ETF has sold 2634 shares on 2025-10-30 at a higher price than the previous selling average. |